Emergent BioSolutions (EBS) Tops Q3 EPS by 31c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.28 --0%
EPS Growth %: -31.3%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
CRMT, More
EPS Growth %: -31.3%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $1.21, $0.31 better than the analyst estimate of $0.90. Revenue for the quarter came in at $311.8 million versus the consensus estimate of $289.27 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
